Swiss Life Asset Management’s Repligen RGEN Stock Holding History

Swiss Life Asset Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$462K	Buy	3,385 +305	+10%	+$37.5K	﹤0.01%	1009
2026 Q1	$363K	Buy	3,080 +603	+24%	+$84.2K	﹤0.01%	1027
2025 Q4	$406K	Hold	2,477	–	–	﹤0.01%	877
2025 Q3	$331K	Buy	+2,477	New	+$301K	﹤0.01%	860
2024 Q1	–	Sell	-2,904	Closed	-$523K	–	611
2023 Q4	$523K	Sell	2,904 -1,007	-26%	-$157K	0.01%	558
2023 Q3	$621K	Sell	3,911 -119	-3%	-$19.5K	0.01%	569
2023 Q2	$571K	Buy	4,030 +1,667	+71%	+$267K	0.01%	558
2023 Q1	$398K	Buy	2,363 +234	+11%	+$41.8K	0.01%	575
2022 Q4	$362K	Buy	+2,129	New	+$386K	0.01%	555

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Swiss Life Asset Management's RGEN Position: Q2 2026 in Review

Swiss Life Asset Management increased its Repligen (RGEN) stake by 9.9% in Q2 2026, buying an estimated $37.5K and bringing the position to 3,385 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #1009.

Swiss Life Asset Management first reported a position in RGEN in Q4 2022 and has held it in 9 quarters since. The position peaked at $621K in Q3 2023. 317 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

Swiss Life Asset Management held 3,385 shares of Repligen worth $462K as of Q2 2026.
Swiss Life Asset Management bought 305 Repligen shares in Q2 2026, an estimated $37.5K.
Repligen made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1009 holding.
Swiss Life Asset Management first reported a position in Repligen in Q4 2022 and has held it in 9 quarters since.
Swiss Life Asset Management's Repligen position peaked at $621K in Q3 2023.
317 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.